Profound Medical Partners with Cook Medical to Expand U.S. Distribution of TULSA-PRO System
Profound Medical (PROF) has entered into a strategic distribution agreement with the interventional MRI division of Cook Medical. The partnership aims to accelerate the domestic sales and adoption of Profound Medical's TULSA-PRO system, an MRI-guided ultrasound technology designed for non-invasive prostate tissue treatment. Under the terms of the deal, Cook Medical will purchase TULSA-PRO systems to facilitate broader market access across the United States. This collaboration leverages Cook Medical's established commercial infrastructure to scale Profound Medical's presence in the interventional oncology sector.